Subaiea GM - Search Results

1

Tolfenamic acid interrupts the de novo synthesis of the β-amyloid precursor protein and lowers amyloid beta via a transcriptional pathway.

Adwan LI, Basha R, Abdelrahim M, Subaiea GM, Zawia NH. Adwan LI, et al. Among authors: subaiea gm. Curr Alzheimer Res. 2011 Jun;8(4):385-92. doi: 10.2174/156720511795745285. Curr Alzheimer Res. 2011. PMID: 21557719

2

The ability of tolfenamic acid to penetrate the brain: a model for testing the brain disposition of candidate Alzheimer's drugs using multiple platforms.

Subaiea GM, Alansi BH, Serra DA, Alwan M, Zawia NH. Subaiea GM, et al. Curr Alzheimer Res. 2011 Dec;8(8):860-7. doi: 10.2174/156720511798192691. Curr Alzheimer Res. 2011. PMID: 21605061

3

Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice.

Subaiea GM, Adwan LI, Ahmed AH, Stevens KE, Zawia NH. Subaiea GM, et al. Neurobiol Aging. 2013 Oct;34(10):2421-30. doi: 10.1016/j.neurobiolaging.2013.04.002. Epub 2013 Apr 30. Neurobiol Aging. 2013. PMID: 23639209 Free PMC article.

4

Infantile exposure to lead and late-age cognitive decline: relevance to AD.

Bihaqi SW, Bahmani A, Subaiea GM, Zawia NH. Bihaqi SW, et al. Among authors: subaiea gm. Alzheimers Dement. 2014 Mar;10(2):187-95. doi: 10.1016/j.jalz.2013.02.012. Epub 2013 Jul 15. Alzheimers Dement. 2014. PMID: 23867794 Free PMC article.

5

Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.

Adwan L, Subaiea GM, Zawia NH. Adwan L, et al. Among authors: subaiea gm. Neuropharmacology. 2014 Apr;79:596-602. doi: 10.1016/j.neuropharm.2014.01.009. Epub 2014 Jan 21. Neuropharmacology. 2014. PMID: 24462621 Free PMC article.

6

Reduction of amyloid-β deposition and attenuation of memory deficits by tolfenamic acid.

Subaiea GM, Ahmed AH, Adwan LI, Zawia NH. Subaiea GM, et al. J Alzheimers Dis. 2015;43(2):425-33. doi: 10.3233/JAD-132726. J Alzheimers Dis. 2015. PMID: 25096618

7

Pomegranate extract modulates processing of amyloid-β precursor protein in an aged Alzheimer's disease animal model.

Ahmed AH, Subaiea GM, Eid A, Li L, Seeram NP, Zawia NH. Ahmed AH, et al. Among authors: subaiea gm. Curr Alzheimer Res. 2014;11(9):834-43. Curr Alzheimer Res. 2014. PMID: 25274111

8

Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.

Adwan L, Subaiea GM, Basha R, Zawia NH. Adwan L, et al. Among authors: subaiea gm. J Neurochem. 2015 Apr;133(2):266-72. doi: 10.1111/jnc.12960. Epub 2014 Oct 18. J Neurochem. 2015. PMID: 25279694 Free PMC article.

9

Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy.

Chang JK, Leso A, Subaiea GM, Lahouel A, Masoud A, Mushtaq F, Deeb R, Eid A, Dash M, Bihaqi SW, Zawia NH. Chang JK, et al. Among authors: subaiea gm. Curr Alzheimer Res. 2018;15(7):655-663. doi: 10.2174/1567205015666180119104036. Curr Alzheimer Res. 2018. PMID: 29357795 Free PMC article.

10

Altered microRNA, mRNA, and Protein Expression of Neurodegeneration-Related Biomarkers and Their Transcriptional and Epigenetic Modifiers in a Human Tau Transgenic Mouse Model in Response to Developmental Lead Exposure.

Masoud AM, Bihaqi SW, Alansi B, Dash M, Subaiea GM, Renehan WE, Zawia NH. Masoud AM, et al. Among authors: subaiea gm. J Alzheimers Dis. 2018;63(1):273-282. doi: 10.3233/JAD-170824. J Alzheimers Dis. 2018. PMID: 29614648 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters